Home › Funds › CANTOR FITZGERALD INVESTMENT ADVISORS L.P. › CVS

CANTOR FITZGERALD INVESTMENT ADVISORS L.P. position in CVS

CVS HEALTH CORP · Consumer Staples

CANTOR FITZGERALD INVESTMENT ADVISORS L.P. reported holding 260,592 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$22.3M, representing 1.25% of its reported portfolio and ranking #15 among its reported holdings. CANTOR FITZGERALD INVESTMENT ADVISORS L.P. has disclosed CVS holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)260.59K sh
Reported value held$22.33M
Portfolio Weight1.25%
First reportedQ4 2023
Last changeAdd
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How CANTOR FITZGERALD INVESTMENT ADVISORS L.P.'s CVS position evolved

CANTOR FITZGERALD INVESTMENT ADVISORS L.P. first disclosed a stake in CVS in Q4 2023 at 295,525 shares (US$23.3M). The position peaked in Q3 2025 at 415,513 shares, worth US$31.3M. Across 12 filings, CANTOR FITZGERALD INVESTMENT ADVISORS L.P. increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 260,592 shares valued at US$22.3M — an increase of 6,402 shares quarter over quarter.. Notable position changes include a 31% increase in Q2 2024 (shares rose 8% over the following quarter), a 31% trim in Q2 2026 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 295.52K $23.33M New
Q1 2024 290.05K $23.13M Reduce
Q2 2024 380.79K $22.49M Add
Q3 2024 381.52K $23.99M Hold
Q4 2024 404.44K $18.16M Add
Q1 2025 403.12K $27.31M Hold
Q2 2025 409.74K $28.26M Add
Q3 2025 415.51K $31.33M Add
Q4 2025 373.95K $29.68M Reduce
Q1 2026 366.37K $26.31M Reduce
Q2 2026 254.19K $26.30M Reduce
Q3 2026 260.59K $22.33M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has CANTOR FITZGERALD INVESTMENT ADVISORS L.P. held CVS?

CANTOR FITZGERALD INVESTMENT ADVISORS L.P. has disclosed CVS holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is CANTOR FITZGERALD INVESTMENT ADVISORS L.P.'s current position in CVS?

As of Q3 2026, CANTOR FITZGERALD INVESTMENT ADVISORS L.P. holds 260.59K shares of CVS (CVS HEALTH CORP), valued at $22.33M, representing 1.25% of its reported portfolio and ranking #15.

Has CANTOR FITZGERALD INVESTMENT ADVISORS L.P. been buying or selling CVS?

In the latest 13F filing (Q3 2026), CANTOR FITZGERALD INVESTMENT ADVISORS L.P. increased its position in CVS. The position peaked in Q3 2025 at 415.51K shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.